TRACE Foundation Announces Recipients of the 2021 TRACE Prize for Investigative Reporting

ANNAPOLIS, Md., June 25, 2021 /PRNewswire/ — The TRACE Foundation, a non-profit organization established to support projects that encourage greater commercial transparency, today announced the winners of the 2021 TRACE Prize for Investigative Reporting. The annual award recognizes journalism that uncovers business bribery or related financial crime.

Zorayda Gallegos Valle, a freelance journalist writing for El País in Mexico, won the TRACE Prize for her investigation that uncovered the Mexican Army’s scheme to divert at least $156 million of public resources through hundreds of shell companies contracted to complete infrastructure projects.

“I am grateful to the TRACE Foundation for supporting investigative journalism because it plays an important role in the transparency and accountability of governments worldwide,” Valle said. “Investigative journalism has become more relevant in Mexico and all over the world. It helps to disclose unlawful activities that authorities want to keep secret, and oversee their actions.”

The second recipient of this year’s TRACE Prize is the FinCEN Files reporting team, which included BuzzFeed News, the International Consortium of Investigative Journalists (ICIJ) and more than 100 media partners. The team undertook a 16-month long investigation, reviewing thousands of financial intelligence documents. They uncovered a flawed oversight process that allowed global banks to profit from suspect transactions. Their reporting has resulted in new reforms and investigations in multiple countries.

“The FinCEN Files investigation exposed how some of the world’s biggest banks play an integral role in the global flow of dirty money,” ICIJ Director Gerard Ryle said. “Our findings have helped push forward important anti-money laundering reforms in some of the globe’s key financial centers, and this recognition from TRACE will help keep the issue in the spotlight.”

ICIJ also earned an honorable mention, along with the rest of the Luanda Leaks team, which includes FRONTLINE, the New York Times and 34 other media partners, for their work exposing the kleptocracy of Isabel dos Santos, daughter of Angola’s former president. They revealed how Western professionals play a vital, little-examined role in the blighting of the lives of countless Angolans.

Ferdinand Ayite of L’Alternative magazine in Togo earned an honorable mention for his Pétrolegate investigation, which found serious financial malpractice among Togolese government officials in charge of importing and pricing petroleum products.

“Even in the face of 2020’s chaotic circumstances, investigative journalists persisted,” TRACE President Alexandra Wrage said. “We commend the important work they do: their bravery, resolve and ingenuity. The TRACE Foundation extends its gratitude to our judges and admiration for our 2021 Prize for Investigative Reporting recipients and their important work.”

The judging panel for the 2021 TRACE Prize for Investigative Reporting included William Gumede, Diana B. Henriques, Rosebell Kagumire, Peter Klein, Donatella Lorch and Jorge Luis Sierra.

The TRACE Foundation will begin accepting submissions for the 2022 TRACE Prize for Investigative Reporting in the fall of 2021. For more details, visit traceinternational.org/investigative-reporting.

About the TRACE Foundation

The TRACE Foundation was established to promote, support and fund research, investigative journalism, publications, videos and related projects that encourage greater commercial transparency and advance anti-bribery education. For more information, visit traceinternational.org/tracefoundation.

أبسن تفوز بقضية الملكية الفكرية لألترافيجين الأمريكية

شنتشن، الصين، 25 يونيو/حزيران 2021 / PRNewswire / — في 12 يونيو/حزيران 2021، قدمت هيئة محلفين اتحادية في محكمة محلية بالولايات المتحدة بالمنطقة الشرقية من تكساس انتصاراً كاملاً لشركة أبسن في دعوى قضائية تتعلق بانتهاك براءات الاختراع. في القضية، زعمت فيها ألترافيجين أن منتجات شاشات العرض الليد من ابسن التي تم تصديرها إلى الولايات المتحدة تنتهك براءات اختراع معينة. لقد وجد حكم هيئة المحلفين بالإجماع أنه لم يتم انتهاك أي من براءات الاختراع المؤكدة في أياً من خطوط المنتجات التسعة التي تم اتهامها في ابسن. قررت هيئة المحلفين أيضاً أن جميع مطالبات البراءات المؤكدة كانت باطلة. جاء الحكم بعد أربعة أيام من سماع الشهادات ونحو ثلاث ساعات من مداولات هيئة المحلفين.

بصفتها شركة رائدة في مجال شاشات العرض الليد والتي تشارك بعمق في السوق الدولية، فقد التزمت ابسن، منذ إنشائها قبل 20 عاماً، بالاستمرار بمبادئها الأساسية للابتكار التكنولوجي واحترام حقوق الملكية الفكرية. بعد بدء مقاضاتها في عام 2018، استجابت أبسن بفاعلية. وقد شكلت فريقاً خاصاً من الخبراء المحليين بالإضافة إلى المحامين الأمريكيين الخارجيين بقيادة شركة جودوين بروكتير للمحاماه. كما دخلت ابسن في شراكة مع شركات أخرى صينية لتصنيع شاشات العرض الليد بما في ذلك جلوكس، و ليارد، وليانترونيك، ويونيلومين. تعني هذه الشراكة أنه يمكن المحافظة على أن تقوم شركة جودوين بروكتير للمحاماه بتنفيذ استراتيجية استجابة مشتركة. مع التخطيط الشامل والجهود من جميع الأطراف، تم تلقي نتيجة ناجحة للغاية في المحكمة الأمريكية وشكرت شركة أبسن جميع المشاركين.

تأسست شركة ابسن في عام 2001، وهي العلامة التجارية الرائدة في عالم شاشات العرض الليد، وتشتهر بمنتجاتها عالية الجودة، والحضور العالمي وقدرات الخدمة الكاملة. تغطي شاشات ابسن مجموعة واسعة من التطبيقات بما في ذلك العرض التجاري، وعرض البيانات، والتأجير والعرض، والحلول الرقمية خارج المنزل والشركات. من خلال الابتكار والتطوير المستمر، كانت شركة ابسن الشركة الصينية رقم 1 في تصدير شاشات الليد لمدة 12 عاماً على التوالي، مما يجعلها العلامة التجارية المفضلة لبعض العلامات التجارية البارزة وشركاء التكامل وشركات التأجير في جميع أنحاء العالم.

في المستقبل، ستحترم شركة ابسن كما هو الحال دائماً، حقوق الملكية الفكرية، وتنغمس بعمق في السوق الدولية وتعمل بجد من أجل احترام السوق الدولية لصناعة شاشات العرض الليد.

الصورة ‎ –  https://mma.prnewswire.com/media/1536501/Victory_Absen_won_U_S_Ultravision_Intellectual_Property_Case.jpg

Synchronoss Technologies, Inc. Announces Pricing of $100 Million Public Offering of Common Stock

BRIDGEWATER, N.J., June 25, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (SNCR) (the “Company” or “Synchronoss”), a global leader and innovator in cloud, messaging and digital products and platforms, today announced the pricing of an underwritten public offering of 38,461,538 shares of its common stock at a public offering price of $2.60 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Synchronoss, are expected to be $100 million. In addition, Synchronoss has granted the underwriters a 30-day option to purchase up to 3,846,154 additional shares of common stock at the public offering price, less the underwriting discounts and commissions.

All of the shares in the offering are being sold by Synchronoss. Synchronoss anticipates using the net proceeds from the offering, and from the offering of Senior Notes and sale of Series B Preferred Stock (each as described below), to fully redeem all outstanding shares of Synchronoss’ Series A Convertible Participating Perpetual Preferred Stock and repay amounts outstanding under Synchronoss’ revolving credit facility. The offering is expected to close on or about June 29, 2021, subject to satisfaction of customary closing conditions.

B. Riley Securities, Inc. (“BRS”) is acting as the lead underwriter and sole book-running manager for the offering. Northland Capital Markets is acting as co-manager for the offering.

Concurrently with the offering, the Company is offering, by means of a separate prospectus supplement, $120 million aggregate principal amount of senior notes due 2026 (the “Senior Notes”). In addition, B. Riley Principal Investments, LLC (“BRPI”), an affiliate of BRS, has entered into an agreement pursuant to which BRPI has agreed to purchase $75.0 million of the Company’s Series B Preferred Stock in a private transaction to be completed concurrently with the closing of the offering.

The shares of common stock described above are being offered by Synchronoss pursuant to a shelf registration statement on Form S-3 previously filed with the Securities and Exchange Commission (SEC) and declared effective by the SEC on August 28, 2020. A preliminary prospectus supplement relating to and describing the terms of the offering is filed with the SEC and is available on the SEC’s web site at www.sec.gov. The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC. Copies of the final prospectus supplement (when available) and accompanying prospectus relating to these securities may also be obtained by sending a request to: B. Riley Securities, Inc., at 1300 North 17th Street, Suite 1300, Arlington, VA 22209 or by calling (703) 312‐9580 or by emailing prospectuses@brileyfin.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Synchronoss

Synchronoss Technologies (NASDAQ: SNCR) builds software that empowers companies around the world to connect with their subscribers in trusted and meaningful ways. The company’s collection of products helps streamline networks, simplify onboarding, and engage subscribers to unleash new revenue streams, reduce costs and increase speed to market.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including but not limited to statements regarding the closing of the public offering and the anticipated use of the proceeds thereof. These forward-looking statements are subject to a number of risks, including the satisfaction of customary closing conditions related to the public offering and the risk factors set forth from time to time in Synchronoss’ SEC filings, including but not limited to the risks that are described in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections (as applicable) of Synchronoss’ Annual Report on Form 10-K for the year ended December 31, 2020 and Quarterly Report on Form 10-Q for the period ended March 31, 2021, which are on file with the SEC and available on the SEC’s website at www.sec.gov. In addition to the risks described above and in Synchronoss’ other filings with the SEC, other unknown or unpredictable factors also could affect Synchronoss’ results. No forward-looking statements can be guaranteed and actual results may differ materially from such statements. The information in this release is provided only as of the date of this release, and Synchronoss undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Media

Diane Rose
CCgroup
synchronoss@ccgrouppr.com

Investors

Todd Kehrli/Joo-Hun Kim
MKR Investor Relations, Inc.
investor@synchronoss.com

Nyxoah Announces Launch of Proposed Public Offering in the United States

REGULATED INFORMATION
INSIDE INFORMATION

Nyxoah Announces Launch of Proposed Public Offering in the United States

Mont-Saint-Guibert, Belgium – June 25, 2021, 12:30 pm CET / 6:30 am ET – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it is launching an underwritten registered public offering of 2,760,000 ordinary shares in the United States (the “Offering”) at an assumed public offering price of $31.461.

In connection with the Offering, Nyxoah intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares offered in the Offering on the same terms and conditions.

The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the size or terms of the Offering, including the price per ordinary share (in USD) and number of ordinary shares sold in the Offering.

Nyxoah’s ordinary shares are currently listed on Euronext Brussels under the symbol “NYXH”. An application has been made to list the ordinary shares on the NASDAQ Global Market under the same symbol.

Piper Sandler, Stifel and Cantor are acting as joint book-running managers for the Offering. Degroof Petercam is acting as a co-manager.

A registration statement on Form F-1 has been filed with the SEC but has not yet become effective. The ordinary shares may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification or publication of an offering prospectus under the securities laws of any such state or jurisdiction.

The Offering will be made only by means of a prospectus. A copy of the preliminary prospectus, when available, can be obtained from Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, by e-mail at prospectus@psc.com, or by phone at (800) 747-3924; Stifel, Nicolaus & Company, Incorporated at Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at (415) 364-2720, or by email at syndprospectus@stifel.com; or Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Avenue, 4th Floor, New York, New York 10022; email: prospectus@cantor.com.

Forward-Looking Statements
This press release includes certain disclosures that contain “forward-looking statements,” including, without limitation, statements regarding the terms of the Offering. Forward-looking statements are based on Nyxoah’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict and could cause actual results to differ. Forward-looking statements contained in this announcement are made as of this date, and Nyxoah undertakes no duty to update such information except as required under applicable law.

IMPORTANT INFORMATION
No public offering will be made and no one has taken any action that would, or is intended to, permit a public offering in any country or jurisdiction, other than the United States, where any such action is required, including in Belgium. Belgian investors, other than qualified investors within the meaning of the Belgian Act of 11 July 2018 on the public offering of securities and the admission of securities to be traded on a regulated market, will not be eligible to participate in the offering (whether in Belgium or elsewhere). The transaction to which this press release relates will only be available to, and will be engaged in only with, in member states of the European Economic Area, persons falling within the meaning of Article 2(e) of Regulation (EU) 2017/1129 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market (the “Prospectus Regulation”), and in the United Kingdom, investment professionals falling within article 19 (5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”), persons falling within article 49 (2), (a) to (d) of the Order and other persons to whom it may lawfully be communicated. A prospectus will be prepared by Nyxoah in accordance with Article 3 of the Prospectus Regulation for the purpose of having the new shares that will be represented by ordinary shares admitted to trading on Euronext Brussels. In the context of the Offering and in accordance with Belgian law and the articles of association of Nyxoah, the board of directors of Nyxoah has approved a conditional capital increase with issuance of up to 4,600,000 ordinary shares within the framework of the authorized capital granted to the board of directors as set out in article 7 of the articles of association of Nyxoah.

Contacts:
Nyxoah
Fabian Suarez, Chief Financial Officer
fabian.suarez@nyxoah.com
+32 10 22 24 55

Gilmartin Group
Vivian Cervantes
IR@nyxoah.com


1 Equivalent to a public offering price of €26.50 per ordinary share, assuming an exchange rate of  €1.00 = $1.1872, the noon buying rate in The City of New York on June 18, 2021 set forth in the H.10 statistical release of the Federal Reserve Board on June 21, 2021.

Attachment

Expert optimistic about China’s chipmaking industry

BEIJING, June 25, 2021 /PRNewswire/ — A news report by China.org.cn on Expert optimistic about China’s chipmaking industry.

The development of China’s domestic chipmaking industry is looking promising as advanced 28 and 14 nanometer (nm) processes are expected to enter mass production by the end of this year and next year respectively, an expert predicted.

Wen Xiaojun, head of the Electronic Information Institute at the China Center for Information Industry Development (CCID), told China’s news portal huanqiu.com, that he was seeing more encouraging signs in China’s chipmaking industry despite technological challenges.

orld Semiconductor Conference & Nanjing International Semiconductor Expo, opens in Nanjing, capital city of east China's Jiangsu province, on June 9. [Photo/VCG]

The country’s 14 nm process has navigated many technology difficulties with significant improvements to manufacturing techniques, packaging technologies and key equipment materials, signaling that the technology for this particular node is going to mature and enter mass production by next year, Wen explained.

“This means that China’s complete reliance on overseas supply chains is coming to an end,” he argued.

According to statistics, the global semiconductor market made around $200 billion in sales in the first half of 2019. The 14 nm chipmaking process accounted for 65% of those sales as it is widely used in fields like high-end consumer electronics, high-speed computing, artificial intelligence and automobiles.

The production lines for 14 nm and 12 nm chipmaking are believed to be critical in the semiconductor industry, as the 14 nm process and above can meet almost 70% of the industry demand for chips, and the 12 nm node can meet the requirements for most mid-end 5G chips.

With cautious optimism, Wen noted that although China’s chipmaking industry is delivering impressive results regarding the 14 nm node, domestic industry stakeholders still need to play catch-up with other global giants in order to bridge the technology gap, which, in his words, “calls for devoting more time, investment, and human resources.”

In an interview earlier in May with weiot.net, a media outlet focused on the Internet-of-Things (IoT) industry, Ni Guangnan, an academician of the Chinese Academy of Engineering, also stressed the importance of staying at the forefront of the advanced chipmaking industry to catch up with other leading countries.

Ni said new technology breakthroughs in the 28 nm and more advanced 14 nm nodes will raise morale in China’s semiconductor industry, and facilitate growth in cutting-edge sectors like new energy vehicles and artificial intelligence.

The World Semiconductor Conference kicked off in Nanjing, capital city of east China’s Jiangsu province, on June 9 this year, showcasing the innovative technology and applications in the semiconductor industry from home and abroad.

Industry leaders such as Taiwan Semiconductor Manufacturing Company (TSMC), Semiconductor Manufacturing International Corporation (SMIC), Synopsys Inc and Montage Technology participated in the conference together with over 300 exhibitors.

According to a report by China Daily, statistics show that the global sales volume of semiconductor products reached $123.1 billion in the first quarter, up 17.8% year-on-year.

Photo – https://mma.prnewswire.com/media/1551475/20210625.jpg

 

Synchronoss Technologies, Inc. Announces Proposed $120 Million Public Offering of Senior Notes

BRIDGEWATER, N.J., June 24, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (SNCR) (the “Company” or “Synchronoss”), a global leader and innovator in cloud, messaging and digital products and platforms, today announced that the Company intends to offer and sell, subject to market and other conditions, $120 million aggregate principal amount of senior notes due 2026 in an underwritten public offering. Synchronoss also expects to grant the underwriters a 30-day option to purchase an additional $5 million aggregate principal amount of senior notes in connection with the offering. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Synchronoss and the senior notes both received a rating of BB- from Egan-Jones Ratings Company, an independent, unaffiliated rating agency.

All of the senior notes in the offering are to be sold by Synchronoss, with net proceeds of the offering, and of the anticipated offering of common stock and sale of Series B Preferred Stock (each as described below), expected to be used to fully redeem all outstanding shares of Synchronoss’ Series A Convertible Participating Perpetual Preferred Stock and repay amounts outstanding under Synchronoss’ revolving credit facility.

B. Riley Securities, Inc. (“BRS”) is acting as the sole book-running manager for the offering. Northland Capital Markets, Aegis Capital Corp. and EF Hutton, division of Benchmark Investments, LLC are acting as lead managers for the offering.

Concurrently with the offering, the Company anticipates offering, by means of a separate prospectus supplement, $100 million of shares of its common stock. In addition, B. Riley Principal Investments, LLC (“BRPI”), an affiliate of BRS, has entered into an agreement pursuant to which BRPI has agreed to purchase $75.0 million of the Company’s Series B Preferred Stock in a private transaction to be completed concurrently with the closing of the offering.

The senior notes described above are being offered by Synchronoss pursuant to a shelf registration statement on Form S-3 previously filed with the Securities and Exchange Commission (SEC) and declared effective by the SEC on August 28, 2020. A preliminary prospectus supplement relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC’s web site at www.sec.gov. The final terms of the proposed offering will be disclosed in a final prospectus supplement to be filed with the SEC. When available, copies of the preliminary prospectus supplement relating to these securities may also be obtained by sending a request to: B. Riley Securities, Inc., at 1300 North 17th Street, Suite 1300, Arlington, VA 22209 or by calling (703) 312‐9580 or by emailing prospectuses@brileyfin.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Synchronoss

Synchronoss Technologies (NASDAQ: SNCR) builds software that empowers companies around the world to connect with their subscribers in trusted and meaningful ways. The company’s collection of products helps streamline networks, simplify onboarding, and engage subscribers to unleash new revenue streams, reduce costs and increase speed to market.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including but not limited to statements regarding the public offering and the anticipated use of the proceeds thereof. These forward-looking statements are subject to a number of risks, including the satisfaction of customary closing conditions related to the proposed public offering and the risk factors set forth from time to time in Synchronoss’ SEC filings, including but not limited to the risks that are described in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections (as applicable) of Synchronoss’ Annual Report on Form 10-K for the year ended December 31, 2020 and Quarterly Report on Form 10-Q for the period ended March 31, 2021, which are on file with the SEC and available on the SEC’s website at www.sec.gov. In addition to the risks described above and in Synchronoss’ other filings with the SEC, other unknown or unpredictable factors also could affect Synchronoss’ results. No forward-looking statements can be guaranteed and actual results may differ materially from such statements. The information in this release is provided only as of the date of this release, and Synchronoss undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Media

Diane Rose
CCgroup
diane@ccgrouppr.com

Investors

Todd Kehrli/Joo-Hun Kim
MKR Investor Relations, Inc.
investor@synchronoss.com

Synchronoss Technologies, Inc. Announces Proposed $100 Million Public Offering of Common Stock

BRIDGEWATER, N.J., June 24, 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (SNCR) (the “Company” or “Synchronoss”), a global leader and innovator in cloud, messaging and digital products and platforms, today announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering. Synchronoss also expects to grant the underwriters a 30-day option to purchase up to an additional $10 million of shares of common stock sold in the offering, at the public offering price, less the underwriting discounts and commissions. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

All of the shares in the offering are to be sold by Synchronoss, with net proceeds of the offering, and from the offering of Senior Notes and sale of Series B Preferred Stock (each as described below), expected to be used to fully redeem all outstanding shares of Synchronoss’ Series A Convertible Participating Perpetual Preferred Stock and repay amounts outstanding under Synchronoss’ revolving credit facility.

B. Riley Securities, Inc. (“BRS”) is acting as the lead underwriter and sole book-running manager for the offering. Northland Capital Markets is acting as co-manager for the offering.

Concurrently with the offering, the Company is offering, by means of a separate prospectus supplement, $120 million aggregate principal amount of senior notes due 2026 (the “Senior Notes”). In addition, B. Riley Principal Investments, LLC (“BRPI”), an affiliate of BRS, has entered into an agreement pursuant to which BRPI has agreed to purchase $75.0 million of the Company’s Series B Preferred Stock in a private transaction to be completed concurrently with the closing of the offering.

The shares of common stock described above are being offered by Synchronoss pursuant to a shelf registration statement on Form S-3 previously filed with the Securities and Exchange Commission (SEC) and declared effective by the SEC on August 28, 2020. A preliminary prospectus supplement relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC’s web site at www.sec.gov. The final terms of the proposed offering will be disclosed in a final prospectus supplement to be filed with the SEC. When available, copies of the preliminary prospectus supplement relating to these securities may also be obtained by sending a request to: B. Riley Securities, Inc., at 1300 North 17th Street, Suite 1300, Arlington, VA 22209 or by calling (703) 312‐9580 or by emailing prospectuses@brileyfin.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Synchronoss

Synchronoss Technologies (NASDAQ: SNCR) builds software that empowers companies around the world to connect with their subscribers in trusted and meaningful ways. The company’s collection of products helps streamline networks, simplify onboarding, and engage subscribers to unleash new revenue streams, reduce costs and increase speed to market.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including but not limited to statements regarding the public offering and the anticipated use of the proceeds thereof. These forward-looking statements are subject to a number of risks, including the satisfaction of customary closing conditions related to the proposed public offering and the risk factors set forth from time to time in Synchronoss’ SEC filings, including but not limited to the risks that are described in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections (as applicable) of Synchronoss’ Annual Report on Form 10-K for the year ended December 31, 2020 and Quarterly Report on Form 10-Q for the period ended March 31, 2021, which are on file with the SEC and available on the SEC’s website at www.sec.gov. In addition to the risks described above and in Synchronoss’ other filings with the SEC, other unknown or unpredictable factors also could affect Synchronoss’ results. No forward-looking statements can be guaranteed and actual results may differ materially from such statements. The information in this release is provided only as of the date of this release, and Synchronoss undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Media

Diane Rose
CCgroup
diane@ccgrouppr.com

Investors

Todd Kehrli/Joo-Hun Kim
MKR Investor Relations, Inc.
investor@synchronoss.com

‫شركة .Advanced Aesthetic Technologies, Inc تُعلن عن علاج أول مريض في تجربة سريرية محورية في الصين باستخدام حشو Algeness® VL ( 2.5٪جل الأغاروز) من أجل تصحيح الطيات الأنفية الشفوية المتوسطة إلى الشديدة

يتم إجراء هذه التجربة السريرية الجديدة من خلال شراكتهم مع شركة Lanzhou Biotechnique Development Co., LTD (شركة لانتشو لتطوير التكنولوجيا الحيوية المحدودة LanDev) وشركتهم الأم China National Biotec Group Co., LTD (مجموعة شركات الصين الوطنية للتكنولوجيا الحيوية المحدودة CNBG)، وسيتم استخدامها للحصول على موافقة التسويق في الصين

بروكلين، ماساتشوستس, 25 يونيو 2021 — /PRNewswire/ تفخر شركة Advanced Aesthetic Technologies, Inc. (AAT) -وهي الشركة الرائدة في تقنية غرسات الجل الجمالية- بالإعلان عن بدء تجربة سريرية لحشو Algeness® VL ( 2.5٪جل الأغاروز) في الصين بالشراكة مع شركة لانتشو لتطوير التكنولوجيا الحيوية المحدودة (LanDev) وشركتهم الأم مجموعة شركات الصين الوطنية للتكنولوجيا الحيوية المحدودة (CNBG)، وتهدف هذه الدراسة إلى تقييم فعالية وسلامة حشو Algeness® VL ( 2.5٪جل الأغاروز) في علاج الطيات الأنفية الشفوية المتوسطة إلى الشديدة باستخدام حشوات حمض الهيالورونيك المتاحة تجاريًا للحَقن كعنصر تحكم.  وستُوفِّر الدراسة المزيد من الأدلة السريرية للمنتَج من أجل التقدم بطلب للحصول على ترخيص التسويق من إدارة الأغذية والأدوية الصينية (NMPA) في بر الصين الرئيسي.

Advanced Aesthetic Technologies, Inc.

وفقًا لدوغ أبيل، الرئيس التنفيذي لشركة AAT، “ينمو سوق مستحضرات التجميل في الصين بشكل أسرع من السوق العالمية.  ويُمثِّل حجم السكان الصينيين والاختراق المنخفض نسبيًا للسوق من مستحضرات التجميل وعلاجات الحشو في الصين إمكانات هائلة للنمو في المستقبل.  إن مجموعتنا الجديدة من حشوات ®Algeness الجلدية هي أول حشوات طبيعية 100٪ متوافقة حيويًا وقابلة للتحلل البيولوجي بالكامل في السوق حتى الآن، مما يميزها عن المنتجات الأخرى القابلة للحَقن.  ويسعدنا أن نبدأ متابعة التسجيل في الصين من خلال شريكنا الاستراتيجي شركة لانتشو لتطوير التكنولوجيا الحيوية المحدودة (LanDev) وشركتهم الأم مجموعة شركات الصين الوطنية للتكنولوجيا الحيوية المحدودة (CNBG)”.

China National Biotec Group Co., LTD

من عام 2015 إلى عام 2019، نما سوق الطب التجميلي العالمي بشكل مطرد، بمعدل نمو سنوي مُركَّب (CAGR) يبلغ حوالي 8.2٪.  نما سوق الصين من 64.8 مليار يوان صيني في عام 2015 إلى 176.9 مليار يوان صيني في عام 2019 – بمعدل نمو سنوي مُركَّب مذهل يبلغ 28.7٪.  يستعد السوق المحلي للنمو بمعدل نمو سنوي مُركَّب يبلغ 15.2٪ بين عامي 2020 و 2023 (مقابل 7٪ عالميًا)، بعد فترة من التعديل.1

عَلَّق وو تشيانغ، المدير العام لشركة لانتشو لتطوير التكنولوجيا الحيوية المحدودة قائلاً، “نحن فخورون بالعمل مع فريق AAT لجلب هذا المنتَج الثوري القابل للحَقن إلى السوق الصينية.  ونحن نؤمن بأن المزايا المتميزة وخصائص السلامة الفائقة لحشو الجل ®Algeness ستتردد صداها لدى أطباء التجميل وتُقدِّم فئة جديدة من المنتجات القابلة للتحلل إلى مجموعة منتجاتنا المتنامية”.

الجدير بالذكر أن ®Algeness هي سلسلة منتجات حشوات جلدية قابلة للامتصاص بالكامل وقابلة للحَقن حاصلة على براءة اختراع، وهي طبيعية 100٪، وتُوفِّر مزايا من حيث السلامة وتجديد شباب البشرة ونتائج تضمن المظهر الطبيعي أثناء حركة الوجه أو ثباته.  وتشمل المزايا السريرية النموذجية الحد الأدنى من التورم عند الحَقن ونتائج ملحوظة على الفور.  كما تحمل حشوات ®Algeness علامة CE ويتم توزيعها حاليًا في أكثر من 30 دولة حول العالم.

حول شركة . Advanced Aesthetic Technologies, Inc

AAT هي شركة عالمية سريعة النمو تعمل على تطوير تقنيات جديدة للطب التجميلي.  وتُعَد منتجاتنا الرئيسية، ألا وهي عائلة غرسات ®Algeness القابلة للحَقن تتويجًا لأكثر من 10 سنوات من البحث العلمي والسريري وتم تطويرها بهدف توفير تطورات عن طريق الحَقن الجمالي في القدرة على تحقيق دعم هيكلي عميق وتعريف نظيف ونتائج سريرية استثنائية، حيث تكون النتيجة في وقت العلاج هي النتيجة النهائية.  وتتميز ®Algeness بأنها حشوات طبيعية 100٪ وقابلة للتحلل الحيوي تعتمد على الأغاروز المنقَّى بخصائص أداء سريري وسلامة متمايز. وتستثمر AAT باستمرار في البحث وتطوير المنتجات من أجل توسيع المعرفة العلمية حول Algeness® وأغاروز، بالإضافة إلى السعي وراء تقنيات جديدة ومبتكرة لتحسين الطب التجميلي وتوسيع مجموعة منتجاتنا.  وحشوات ®Algeness حاصلة على علامة CE، ولديها العديد من التسجيلات الإضافية على مستوى الدولة، وهي متاحة حاليًا في أكثر من 30 دولة.  AAT بصدد متابعة التسجيل في الولايات المتحدة من خلال إدارة الغذاء والدواء (FDA). www.algeness.com

حول شركة لانتشو لتطوير التكنولوجيا الحيوية المحدودة ( LanDev ) وشركتهم الأم مجموعة شركات الصين الوطنية للتكنولوجيا الحيوية المحدودة ( CNBG )

تأسست مجموعة شركات الصين الوطنية للتكنولوجيا الحيوية المحدودة (CNBG) في عام 1919، وهي شركة فرعية مملوكة بالكامل لمجموعة شركات الصين الوطنية للأدوية المحدودة، إحدى أكبر 500 شركة في العالم.  كشركة أدوية حيوية شاملة، فإن CNBG لديها تاريخ طويل مع خطوط إنتاج كاملة ونطاق واسع، ودمج البحث العلمي، والإنتاج، والمبيعات، والتدريب بعد التخرج.  وتغطي خطوط إنتاج CNBG ستة مجالات رئيسية للمنتجات الحيوية، بما في ذلك اللقاحات البشرية، ومنتجات الدم، والجمال الطبي، وصحة الحيوان، وأدوية الأجسام المضادة، والتشخيص الطبي.  www.cnbg.com.cn

شركة لانتشو لتطوير التكنولوجيا الحيوية المحدودة (LanDev)، هي شركة احترافية صحية رائدة في مجال الطب والجمال في الصين.  وتغطي أعمالها توكسين البوتولينوم، وحمض الهيالورونيك، والكولاجين، ومعدات التجميل بالليزر، إلخ. و LanDev هي الشركة المصنعة الحصرية لتوكسين البوتولينوم ®A (BTXA)-Hengli في الصين التي تتمتع بحصة سوقية تقارب 70٪ لـ BTXA في الصين.  وقد تم بيع ®Hengli لأكثر من 20 عامًا، ووصلت حالات الاستخدام السريري إلى أكثر من عشرة ملايين حالة.  وفي الوقت نفسه، فإن LanDev هي الموزع الحصري لشركة Princess في بر الصين الرئيسي، وهي حشوات حمض الهيالورونيك التي تنتجها شركة CROMA-Pharma GmbH، وهي شركة نمساوية.  كما أنشأت LanDev أيضًا شراكة استراتيجية عميقة مع شركة Cynosure الأمريكية الرائدة في الصناعة.  وقد أصبحت LanDev شركة مبتكرة تقود تطوير الصناعة المحلية من خلال قدرتها التنافسية الدولية المتنامية والاحترام الاجتماعي.

الاتصال:  filler@algeness.com

1 https://www2.deloitte.com/cn/en/pages/life-sciences-and-healthcare/articles/china-aesthetic-medicine-market-outlook.html

الشعار من – https://mma.prnewswire.com/media/1550223/AAT_Logo.jpg
الشعار من – https://mma.prnewswire.com/media/1550093/CNBG_Logo.jpg

تعيين سيباستيان سميث مديرًا عامًا إقليميًا لشركة أوكتاجون الشرق الأوسط وشمال إفريقيا

الدوحة مقر شراكة أوكتاجون وأكبر مجموعة وكالات الاعلان  IPG/MCN Group   تحت اسم “ Home Advantage

الدوحة، قطر، 24 يونيو 2021أعلنت شركة أوكتاجون، وكالة التسويق والإبداع وإدارة المواهب البارزة في مجال الرياضة والترفيه العالمية؛ بالشراكة مع شبكة اتصالات الشرق الأوسط (MCN) التابعة لشركة IPG، المجموعة الإقليمية الرائدة من وكالات الإعلان والتسويق، عن تعيين سيباستيان سميث مديرًا عامًا إقليميًا لشركة أوكتاجون في الشرق الأوسط وشمال إفريقيا.

SEBASTIAN SMITH, REGIONAL GENERAL MANAGER OF OCTAGON MIDDLE EAST AND NORTH AFRICA

 وتأتي هذه الخطوة ضمن خطة شركة أوكتاجون لتعزيز تواجدها في الشرق الأوسط وشمال إفريقيا، من خلال ضم خبرة الشركة العالمية إلى أفضل القدرات والمواهب التي لدى وكالات التسويق الإقليمية وتقديم حلول متكاملة في مجال الرياضة والترفيه. وخلال إدارته لعمليات أوكتاجون سيُشرف سميث على المكتب الإقليمي الذي يقع في مقر مجموعةMCN  في الدوحة، بهدف إلى زيادة فرص الرياضة والترفيه في المنطقة إنطلاقاً من العاصمة التي ستستضيف كأس العالم FIFA قطر 2022.

وسيعزز التواجد في الدوحة التعاون الوثيق مع الوكالات المتواجدة في الدوحة كـ FP7/McCann و UM و Jack Morton و Weber Shandwick، والتي تعتبر جزء من عرض مجموعة “Home Advantage” الخاصة بـ MCN، ولخلق وضع مثالي لتقديم الاستشارات الاستراتيجية والإبداعية والتجريبية وفق احتياجات العملاء الجدد والحاليين ترقباً للحدث العالمي في العام المقبل.

كما سيقوم كل من أيكان أزار المدير العام لشركة أوكتاجون في منطقة آسيا والحيط الهادي (Octagon APAC) ومنطقة الشرق الأوسط وأفريقيا، ومارك لاواندوس، المدير العام لشركة أوكتاجون في الشرق الأوسط و FP7/McCann في المملكة العربية السعودية في مجموعةMCN بالإشراف على المكتب.

وصرح أزار قائلاً: “إن خبرة سيباستيان الواسعة المختصة في الرياضة والفعاليات الدولية الكبرى، بالإضافة إلى سجله الحافل في شتى مناحي المجال، تجعله الشخص المثالي لأعمالنا وعملائنا في المنطقة”.

كما صرح لاواندوس: “استعدادًا لبطولة كأس العالم لكرة القدم 2022، يقوم دور سيباستيان بتسخير القوة التعاونية والمعرفة المحلية الواسعة لشبكتنا بطريقة فريدة من نوعها، لخلق حلول لا مثيل لها للعملاء المحليين والعالميين؛ ولذلك اطلقنا على مكتبنا الجديد اسم “Home Advantage” أو “الميزة المحلية””.

وعلّق سميث: “أعتقد أن الدخول إلى مثل هذه المنطقة الواعدة في هذا التوقيت هو أمر بالغ الأهمية، ويشرفني القيام بذلك مع دعم من الفرق المشتركة في كل من شركة أوكتاجون ومجموعة MCN “.

انتقل سميث إلى الشرق الأوسط في مارس من العام الجاري، بعد أن أمضى خمس سنوات في لندن بصفته نائب الرئيس التنفيذي الأول لمكتب أوكتاجون في أوروبا، حيث كان جزءًا من القيادة الإقليمية التي تعتبر مسؤولة عن العملاء الرئيسيين بالإضافة إلى التسويق وتطوير الأعمال.

نبذة عن شركة أوكتاجون:

أوكتاجون (Octagon) هي وكالة التسويق والإبداع وإدارة المواهب المتكاملة البارزة في مجال الرياضة والترفيه العالمية. كما تنشئ الوكالة حملات تسويقية مميزة لبعض من أكبر العلامات التجارية وقائمة شركات فورتشين 500 (Fortune 500) في جميع أنحاء العالم وتمثل أكثر من 900 من أبرز الرياضيين والمواهب والعقارات وأكثرها نفوذاً في العالم.

ومن خلال أكثر من 1,000 موظف حول العالم، ومقرهم في 50 مكتبًا، في 20 دولة، تتبوء شركة أوكتاجون مكانتها في جميع مجالات الرياضة والترفيه تقريبًا.

وعلى مدار أكثر من 40 عامًا، دفعت شركة أوكتاجون استمرار حدود الصناعة من خلال حملات تسويقية رائدة، وخدمات تجريبية وضيافة، وبيانات رائدة في الصناعة، ورؤى، وقدرات إستراتيجية، بالإضافة إلى محفظة إدارة مواهب لا مثيل لها من أعلى -الملف الشخصي والرياضيين والشخصيات الناجحة.

الصورة- https://mma.prnewswire.com/media/1549693/Octagon.jpg

The Ministry of Foreign Affairs and International Cooperation, Sorbonne University sign agreement to support education in Africa

The Ministry of Foreign Affairs and International Cooperation (MoFAIC) has signed a cooperation agreement with Sorbonne University Abu Dhabi (SUAD) to support the education sector in a number of African countries.

In a virtual ceremony held recently, the agreement was signed by Sultan Al Shamsi, Assistant Minister of Foreign Affairs and International Cooperation for International Development Affairs, and Prof. Silvia Serrano, Vice-Chancellor of Sorbonne University Abu Dhabi.

The agreement comes in line with the UAE’s efforts to strengthen and support the education sector in several African nations by providing 60 undergraduate full scholarships for qualified students from French-speaking African countries to pursue their studies at Sorbonne University Abu Dhabi.

This agreement, which comes against the backdrop of the COVID-19 pandemic, is considered an opportunity for such countries to build the competencies of their human capital, which is the primary pillar for development. It will also empower African youth to build a better future and contribute to achieving the sustainable development of their countries and local communities.

The agreement is expected to take effect in September 2021, allowing students to enrol in the 2021/2022 academic year.

Commenting on the agreement, Prof. Serrano said, “With this initiative, Sorbonne University Abu Dhabi is pleased to be able to contribute to the pivotal role that the UAE plays in developing the global education landscape, and we look forward to seeing the positive impact this cooperation will have on enhancing the educational and professional development of human capital in African countries.”

“I am confident that through this agreement, we will empower youth and contribute to the development of their intellectual capacity by allowing them to receive a world-class education that will have a major impact on their future and the long-term roles they will play in the economic development of their native countries,” she added.

Providing these scholarships for partner countries is part of the UAE’s Foreign Aid Policy, which aims to support the government in building the capacities of countries and developing their national human capital.

Through its Technical Assistance Programme (UAETAP), the UAE works to implement programmes to support developing countries by facilitating technical cooperation activities that draw upon the lessons learnt from the UAE’s developmental experience.

UAETAP provides its services in cooperation with the competent UAE government and business institutions. In addition, the UAE works in close collaboration with donor countries and international partners to provide technical cooperation programmes for beneficiary countries.

Since 2018, approximately 1,694 students from 70 countries, including 650 female students, were registered in scholarship programmes in the UAE’s higher education institutions. Among those were 725 male and female African students in different Emirati universities.

Source: UAE Ministry of Foreign Affairs